Author/Authors :
Bahador, Ali shiraz university of medical sciences - Nemazee Hospital - Shiraz Organ Transplantation Center, شيراز, ايران , Bahador, Ali University of Cape Town - Groote Schuur Hospital - Divisions of Hypertension and Nephrology, South Africa , Salahi, Heshmatollah shiraz university of medical sciences - Nemazee Hospital - Shiraz Organ Transplantation Center, شيراز, ايران , Salehipour, Mehdi shiraz university of medical sciences - Nemazee Hospital - Shiraz Organ Transplantation Center, شيراز, ايران , Davari, Hamidreza shiraz university of medical sciences - Nemazee Hospital - Shiraz Organ Transplantation Center, شيراز, ايران , Kazemi, Korosh shiraz university of medical sciences - Nemazee Hospital - Shiraz Organ Transplantation Center, شيراز, ايران , Malek-Hosseini, Ali shiraz university of medical sciences - Nemazee Hospital - Shiraz Organ Transplantation Center, شيراز, ايران
Abstract :
Renal transplantation is the optimal treatment for patients with end-stage renal disease (ESRD). Although the number of patients with ESRD awaiting kidney transplantation is rapidly increasing, the donor pool remains relatively stable. Due to this discrepancy, kidneys with congenital anomalies should be considered as an additional source of organs for transplantation.
